Cite
Outcomes of treatment with daclatasvir and asunaprevir for recurrent hepatitis C after liver transplantation
MLA
Masaki, Honda, et al. “Outcomes of Treatment with Daclatasvir and Asunaprevir for Recurrent Hepatitis C after Liver Transplantation.” Hepatology Research : The Official Journal of the Japan Society of Hepatology, vol. 47, no. 11, Oct. 2016. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........10077def5e8ff44dfb44526c602b0402&authtype=sso&custid=ns315887.
APA
Masaki, H., Yasuhiko, S., Takehisa, W., Masakuni, T., Motohiko, T., Koushi, U., Seiichi, K., Daiki, Y., Kouhei, M., Kaori, I., Shintaro, H., Yuki, O., Hidekazu, Y., Yutaka, S., & Yukihiro, I. (2016). Outcomes of treatment with daclatasvir and asunaprevir for recurrent hepatitis C after liver transplantation. Hepatology Research : The Official Journal of the Japan Society of Hepatology, 47(11).
Chicago
Masaki, Honda, Sugawara Yasuhiko, Watanabe Takehisa, Tateyama Masakuni, Tanaka Motohiko, Uchida Koushi, Kawabata Seiichi, et al. 2016. “Outcomes of Treatment with Daclatasvir and Asunaprevir for Recurrent Hepatitis C after Liver Transplantation.” Hepatology Research : The Official Journal of the Japan Society of Hepatology 47 (11). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........10077def5e8ff44dfb44526c602b0402&authtype=sso&custid=ns315887.